Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Are the latest drugs fit for purpose in MAPK/ERK and PI3K signalling pathways?

Date

21 Dec 2015

Session

Translating emerging therapeutics into clinical use

Presenters

Fortunato Ciardiello

Authors

F. Ciardiello

Author affiliations

Second University of Naples, 80131 - Naples/IT

More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

21 Dec 2015

What lessons can we learn from targeting cMET and IGFR in GI cancers?

Presenter: Ian Chau

Session: Translating emerging therapeutics into clinical use

Resources:

Presentation

Webcast

21 Dec 2015

Targeting angiogenesis in GI cancers

Presenter: Kei Muro

Session: Translating emerging therapeutics into clinical use

Resources:

Presentation

Webcast

21 Dec 2015

Manipulating immune system in GI cancer

Presenter: Benoit van den Eynde

Session: Translating emerging therapeutics into clinical use

Resources:

Presentation

Webcast